China's US M&A woes are only just warming up

The Trump administration is beginning to back up its beligerent words with action, and deals in the biotech and semiconductors sectors are at particular risk.
US Trade Representative Robert Lighthizer has begun an investigation under Section 301 of the Trade Act of 1974, a move seen as firing the first shot in a trade war with China.
US Trade Representative Robert Lighthizer has begun an investigation under Section 301 of the Trade Act of 1974, a move seen as firing the first shot in a trade war with China.
August 31, 2017

When the tub-thumping campaign rhetoric of candidate Donald Trump was transformed, against all expectations, into a narrow election victory, there was little doubt that the path ahead for acquisitive Chinese conglomerates would be tougher.

¬ Haymarket Media Limited. All rights reserved.

Sign in to read on!

Registered users get 2 free articles in 30 days.

Subscribers have full unlimited access to FinanceAsia.

Not signed up? New users get 2 free articles per month, plus a 7-day unlimited free trial.

Questions?
See here for more information on licences and prices, or contact [email protected].

Related Articles

Trump, Beijing won't ground US deals: HNA chief

Adam Tan, CEO of the Chinese airlines-to-property conglomerate, says a grim regulatory environment and questions over its ownership and finances won't stop dealmaking.
September 26, 2017